GlassScriptPrepare for your visit
Sheldon L Brownstein
Cardiovascular Disease · Fort Myers, FL · NPI 1174520464
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$2,027.87
in general payments reported to CMS, 2019-2025 · $841 in 2025
The $841 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Who reported paying
General payments only, top 6 by amount.
- Novartis Pharmaceuticals Corporation $535.60
- Medtronic, INC. $236.61
- Alnylam Pharmaceuticals INC. $230.16
- Cvrx, INC. $144.59
- Pfizer INC. $111.81
- Boston Scientific Corporation $95.36
Drugs and devices associated with these payments
Leqvio Barostim Neo System Entresto Micra Amvuttra Onpattro Aurora Ev-Icd Mri Surescan Kerendia Verquvo Vyndaqel Ffrct Attruby
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Sheldon Brownstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/53366/sheldon-l-brownstein